Chorionic Gonadotropin Market By Type (Human Chorionic Gonadotropin (HCG), Animal Chorionic Gonadotropin), By Application (Research institutions, Pharmaceutical), By technology (Natural source extraction, Recombinant DNA technology), By therapeutic area (Female infertility treatment, Oligospermia treatment, Cryptorchidism treatment), Industry Trends, Estimation & Forecast, 2017-2025

Chorionic Gonadotropin Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Chorionic gonadotropin is similar to luteinizing hormone (LH) in function, which is secreted by placenta while the embryo is developing during the pregnancy. This hormone, when administrated with combination of other drugs, helps women to conceive. Apart from that, chorionic gonadotropin along with LH stimulates the production of testosterone in males. Increasing infertility rates worldwide is the major factor which is driving the growth of chorionic gonadotropin market. As per the statistics declared by Maternal Health Task Force, today, infertility is experienced by approximately 50 million couples all around the world. Other factors which are contributing to the market growth include changing lifestyle, increasing maternity age, oligospermia, hormonal dysfunctions in both men and women, and tilting orientation of people towards hormonal drug therapies. Moreover, it has also been found that the reproductive performance of veterinary animals is also improved by the clinical use of chorionic gonadotropin extracted from human origin. For example Chorulon®, which contains the complex glycoprotein, is used in the treatment of cattle, horses, dogs, goats, pigs and queen cats for improving conception and other reproductive ailments. However, substitutes to chorionic gonadotropin treatment such as insemination and in vitro fertilization (IVF) are the challenges which can obstruct the growth of the chorionic gonadotropin market. The report provides detailed qualitative and quantitative analysis of the chorionic gonadotropin market. Market size and forecast in terms of value and volume has been provided for the period - (2018 - 2025), for the segments namely type, application, technology, therapeutic area in each of the major regions.

Chorionic Gonadotropin Market Segmentation

By Type • Human Chorionic Gonadotropin (HCG) • Animal Chorionic Gonadotropin By Application • Research institutions • Pharmaceutical • Others By technology  • Natural source extraction • Recombinant DNA technology By therapeutic area  • Female infertility treatment • Oligospermia treatment • Cryptorchidism treatment • Others By geography • North America o U.S. o Canada o Mexico • Europe o U.K. o France o Germany o Italy o Spain o Rest of Europe • Asia-Pacific o China o Japan o India o Korea o Rest of APAC • South America o Brazil o Rest of South America • Rest of the World o Middle East o Africa

CHAPTER 1.INTRODUCTION
1.1.RESEARCH METHODOLOGY
1.1.1.ERC desk research
1.1.2.ERC data synthesis
1.1.3.Data validation and market feedback
1.1.4.ERC data sources

CHAPTER 2.CHORIONIC GONADOTROPIN MARKET OVERVIEW
2.1.CHORIONIC GONADOTROPIN MARKET INTRODUCTION
2.2.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1.Global Chorionic Gonadotropin Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3.GLOBAL CHORIONIC GONADOTROPIN MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1.Global Chorionic Gonadotropin Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1.Global Chorionic Gonadotropin Consumption (VOLUME) and Growth Rate (%), (2017-2025)

CHAPTER 3.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TYPE, 2017-2025
3.1.HUMAN CHORIONIC GONADOTROPIN (HCG)
3.2.ANIMAL CHORIONIC GONADOTROPIN
3.3.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY TYPE, 2017-2025
3.3.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Type, 2017-2025
3.3.2.Human Chorionic Gonadotropin (HCG) Market Revenue and Growth Rate, 2017-2025
3.3.3.Animal Chorionic Gonadotropin Market Revenue and Growth Rate, 2017-2025
3.4.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION BY TYPE, 2017-2025
3.4.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Type, 2017-2025
3.4.2.Human Chorionic Gonadotropin (HCG) Market Production and Growth Rate, 2017-2025
3.4.3.Animal Chorionic Gonadotropin Market Production and Growth Rate, 2017-2025

CHAPTER 4.GLOBAL CHORIONIC GONADOTROPIN MARKET BY APPLICATION, 2017-2025
4.1.RESEARCH INSTITUTIONS
4.2.PHARMACEUTICAL
4.3.OTHERS
4.4.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2.Research institutions Market Revenue and Growth Rate, 2017-2025
4.4.3.Pharmaceutical Market Revenue and Growth Rate, 2017-2025
4.4.4.Others Market Revenue and Growth Rate, 2017-2025
4.5.GLOBAL CHORIONIC GONADOTROPIN MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1.Global Chorionic Gonadotropin Market Consumption (Volume) and share (%) By Application, 2017-2025
4.5.2.Research institutions Market Consumption and Growth Rate, 2017-2025
4.5.3.Pharmaceutical Market Consumption and Growth Rate, 2017-2025
4.5.4.Others Market Consumption and Growth Rate, 2017-2025

CHAPTER 5.GLOBAL CHORIONIC GONADOTROPIN MARKET BY TECHNOLOGY, 2017-2025
5.1.NATURAL SOURCE EXTRACTION
5.2.RECOMBINANT DNA TECHNOLOGY

CHAPTER 6.GLOBAL CHORIONIC GONADOTROPIN MARKET BY THERAPEUTIC AREA, 2017-2025
6.1.FEMALE INFERTILITY TREATMENT
6.2.OLIGOSPERMIA TREATMENT
6.3.CRYPTORCHIDISM TREATMENT
6.4.OTHERS

CHAPTER 7.GLOBAL CHORIONIC GONADOTROPIN MARKET BY REGION, 2017-2025
7.1.NORTH AMERICA
7.1.1.U.S.
7.1.2.Canada
7.1.3.Mexico
7.2.EUROPE
7.2.1.U.K.
7.2.2.France
7.2.3.Germany
7.2.4.Italy
7.2.5.Spain
7.2.6.Rest of Europe
7.3.ASIA PACIFIC
7.3.1.China
7.3.2.Japan
7.3.3.India
7.3.4.Korea
7.3.5.Rest of APAC
7.4.SOUTH AMERICA
7.4.1.Brazil
7.4.2.Rest of South America
7.5.REST OF THE WORLD
7.5.1.Middle East
7.5.2.Africa
7.6.GLOBAL CHORIONIC GONADOTROPIN MARKET REVENUE BY REGION, 2017-2025
7.6.1.Global Chorionic Gonadotropin Market Revenue (Million USD) and Share (%) By Region, 2017-2025
7.6.2.North America Market Revenue and Growth Rate, 2017-2025
7.6.3.Europe Market Revenue and Growth Rate, 2017-2025
7.6.4.Asia Pacific Market Revenue and Growth Rate, 2017-2025
7.6.5.South America Market Revenue and Growth Rate, 2017-2025
7.6.6.Rest of the World Market Revenue and Growth Rate, 2017-2025

CHAPTER 8.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
8.1.GLOBAL CHORIONIC GONADOTROPIN MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
8.1.1.Global Chorionic Gonadotropin Market Production (Volume) and Share (%) By Region, 2017-2025
8.1.2.Global Chorionic Gonadotropin Market Consumption (Volume) and Share (%) By Region, 2017-2025
8.1.3.North America Market Production and Consumption, 2017-2025
8.1.4.Europe Market Production and Consumption, 2017-2025
8.1.5.Asia Pacific Market Production and Consumption, 2017-2025
8.1.6.South America Market Production and Consumption, 2017-2025
8.1.7.Rest of the World Market Production and Consumption, 2017-2025

CHAPTER 9.MARKET DETERMINANTS
9.1.MARKET DRIVERS
9.2.MARKET RESTRAINTS
9.3.MARKET OPPORTUNITIES
9.4.MARKET DETERMINANTS RADAR CHART

CHAPTER 10.GLOBAL CHORIONIC GONADOTROPIN MARKET COMPETITION BY MANUFACTURERS
10.1.GLOBAL CHORIONIC GONADOTROPIN PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
10.1.1.Global Chorionic Gonadotropin Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
10.2.GLOBAL CHORIONIC GONADOTROPIN REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
10.2.1.Global Chorionic Gonadotropin Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
10.3.CHORIONIC GONADOTROPIN MARKET COMPETITIVE SITUATION AND TRENDS
10.3.1.Chorionic Gonadotropin Market Share (%) of Top 3 Manufacturers
10.3.2.Chorionic Gonadotropin Market Share (%) of Top 5 Manufacturers

CHAPTER 11.GLOBAL CHORIONIC GONADOTROPIN MANUFACTURERS ANALYSIS
11.1.EMD SERONO, INC.
11.1.1.Business Overview
11.1.2.Company Basic Information
11.1.3.Chorionic Gonadotropin Product Details
11.1.4.EMD Serono, Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.2.FERRING B.V.
11.2.1.Business Overview
11.2.2.Company Basic Information
11.2.3.Chorionic Gonadotropin Product Details
11.2.4.Ferring B.V. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.3.MERCK & CO., INC.
11.3.1.Business Overview
11.3.2.Company Basic Information
11.3.3.Chorionic Gonadotropin Product Details
11.3.4.Merck & Co., Inc. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.4.BRISTOL MYERS SQUIBB COMPANY
11.4.1.Business Overview
11.4.2.Company Basic Information
11.4.3.Chorionic Gonadotropin Product Details
11.4.4.Bristol Myers Squibb Company Chorionic Gonadotropin Production, Revenue and Gross Margin
11.5.FRESENIUS KABIUSA, LLC.
11.5.1.Business Overview
11.5.2.Company Basic Information
11.5.3.Chorionic Gonadotropin Product Details
11.5.4.Fresenius KabiUSA, LLC. Chorionic Gonadotropin Production, Revenue and Gross Margin
11.6.SCRIPPSLABS
11.6.1.Business Overview
11.6.2.Company Basic Information
11.6.3.Chorionic Gonadotropin Product Details
11.6.4.Scrippslabs Chorionic Gonadotropin Production, Revenue and Gross Margin
11.7.LEEBIO
11.7.1.Business Overview
11.7.2.Company Basic Information
11.7.3.Chorionic Gonadotropin Product Details
11.7.4.Leebio Chorionic Gonadotropin Production, Revenue and Gross Margin
11.8.KAMIYA BIOMEDICAL COMPANY
11.8.1.Business Overview
11.8.2.Company Basic Information
11.8.3.Chorionic Gonadotropin Product Details
11.8.4.Kamiya Biomedical Company Chorionic Gonadotropin Production, Revenue and Gross Margin
11.9.CIGNA
11.9.1.Business Overview
11.9.2.Company Basic Information
11.9.3.Chorionic Gonadotropin Product Details
11.9.4.Cigna Chorionic Gonadotropin Production, Revenue and Gross Margin
11.10.SANZYME
11.10.1.Business Overview
11.10.2.Company Basic Information
11.10.3.Chorionic Gonadotropin Product Details
11.10.4.Sanzyme Chorionic Gonadotropin Production, Revenue and Gross Margin

• EMD Serono, Inc.
• Ferring B.V.
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Fresenius KabiUSA, LLC.
• Scrippslabs
• Leebio
• Kamiya Biomedical Company
• Cigna
• Sanzyme

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS